SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
cis2014
Lv6
2060 积分
2022-08-25 加入
最近求助
最近应助
互助留言
Target and tissue selectivity of PROTAC degraders
29天前
已完结
Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
29天前
已完结
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
29天前
已完结
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
29天前
已完结
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders
29天前
已完结
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
29天前
已完结
Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation
1个月前
已完结
Strategies to therapeutically modulate cytokine action
6个月前
已完结
Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors
7个月前
已完结
Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019–2021)
7个月前
已完结
没有进行任何应助
感谢
29天前
感谢
29天前
感谢
29天前
感谢
29天前
感谢
29天前
感谢
29天前
感谢
1个月前
速度真快
9个月前
速度真快
9个月前
速度真快,帮大忙了
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论